Instituto de Biomedicina de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Cell type-specific adaptation of the SARS-CoV-2 spike

    Virus Evolution, Vol. 10, Núm. 1

2023

  1. C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein

    Journal of Medicinal Chemistry, Vol. 66, Núm. 15, pp. 10432-10457

  2. Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant

    Journal of Medical Virology, Vol. 95, Núm. 1

2022

  1. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection

    Journal of Medical Virology, Vol. 94, Núm. 9, pp. 4216-4223

  2. Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. e865-e868

  3. The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

    PLoS Pathogens, Vol. 18, Núm. 7 July

2021

  1. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2

    mBio, Vol. 12, Núm. 6

2020

  1. SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients

    Journal of Clinical Virology, Vol. 131